Correlation Between Edgewise Therapeutics and Cassava Sciences
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Cassava Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Cassava Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Cassava Sciences, you can compare the effects of market volatilities on Edgewise Therapeutics and Cassava Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Cassava Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Cassava Sciences.
Diversification Opportunities for Edgewise Therapeutics and Cassava Sciences
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Cassava is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Cassava Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cassava Sciences and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Cassava Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cassava Sciences has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Cassava Sciences go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Cassava Sciences
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Cassava Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 3.05 times less risky than Cassava Sciences. The stock trades about -0.14 of its potential returns per unit of risk. The Cassava Sciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 2,655 in Cassava Sciences on August 26, 2024 and sell it today you would lose (7.00) from holding Cassava Sciences or give up 0.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Cassava Sciences
Performance |
| Timeline |
| Edgewise Therapeutics |
| Cassava Sciences |
Edgewise Therapeutics and Cassava Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Cassava Sciences
The main advantage of trading using opposite Edgewise Therapeutics and Cassava Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Cassava Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cassava Sciences will offset losses from the drop in Cassava Sciences' long position.| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals |
| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |